Skip to main content
Clinical Trials/CTRI/2022/05/042683
CTRI/2022/05/042683
Completed
Phase 2

Comparative evaluation of the injectable platelet rich fibrin (i-PRF) with and without micro-needling for gingival augmentation in thin gingival phenotype - A randomized clinical trial

DR B NAMRATHA SAI0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: R69- Illness, unspecified
Sponsor
DR B NAMRATHA SAI
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 15, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
DR B NAMRATHA SAI

Eligibility Criteria

Inclusion Criteria

  • Age18\- 45years.
  • Gingival thickness of mandibular anterior and premolars with thin gingival phenotype (\= 0\.8mm.)
  • No blood borne conditions.
  • Full mouth plaque index and Bleeding on probing score \=15% (total score should be less than \=15% of the maximum score).
  • Systemically healthy patients.

Exclusion Criteria

  • Active orthodontic treatment.
  • Use of tobacco in any form.
  • Previous periodontal surgery.
  • Systemic diseases.
  • Use of blood thinners.
  • Use of any drug that might lead to gingival enlargement.
  • Malocclusion, crowding, fillings, missing and supernumerary teeth.

Outcomes

Primary Outcomes

Not specified

Similar Trials